OBJECTIVE
To evaluate the behaviour of an oral matrix modified release formulation in the canine gastrointestinal tract, and establish if a mechanical weakness previously observed in clinical studies would have been identified in the dog model.
METHODS
In vitro release profiles were obtained for two